Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$7.77 - $10.61 $40,404 - $55,172
-5,200 Reduced 13.94%
32,100 $340,000
Q4 2023

Feb 14, 2024

BUY
$6.53 - $8.23 $243,569 - $306,979
37,300 New
37,300 $299,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $23.63 $14 Million - $46.8 Million
1,981,800 New
1,981,800 $16.6 Million
Q3 2021

Nov 15, 2021

SELL
$25.04 - $30.06 $12.3 Million - $14.8 Million
-491,400 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$27.43 - $32.7 $13.5 Million - $16.1 Million
491,400 New
491,400 $14.4 Million
Q1 2021

May 17, 2021

SELL
$21.37 - $34.38 $74.1 Million - $119 Million
-3,468,900 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$15.31 - $21.12 $5.52 Million - $7.61 Million
-360,357 Reduced 9.41%
3,468,900 $72.2 Million
Q3 2020

Nov 16, 2020

BUY
$14.88 - $20.13 $36.1 Million - $48.8 Million
2,426,392 Added 172.96%
3,829,257 $59.5 Million
Q2 2020

Aug 14, 2020

BUY
$13.31 - $20.51 $18.7 Million - $28.8 Million
1,402,865 New
1,402,865 $25.7 Million
Q4 2019

Feb 14, 2020

SELL
$18.89 - $31.89 $41.6 Million - $70.2 Million
-2,200,679 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$20.88 - $25.66 $17.1 Million - $21 Million
819,281 Added 59.31%
2,200,679 $48.1 Million
Q2 2019

Aug 14, 2019

BUY
$20.52 - $26.45 $28.3 Million - $36.5 Million
1,379,426 Added 69950.61%
1,381,398 $34.8 Million
Q1 2019

May 15, 2019

SELL
$20.23 - $26.29 $3.5 Million - $4.55 Million
-173,028 Reduced 98.87%
1,972 $49,000
Q4 2018

Feb 14, 2019

SELL
$17.64 - $28.32 $1.88 Million - $3.02 Million
-106,700 Reduced 37.88%
175,000 $3.23 Million
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $5.81 Million - $7.23 Million
281,700 New
281,700 $7.23 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.